capacity and Citeline Connect have collaborated to introduce a clinical trial recruitment website featuring artificial intelligence (AI)-driven chatbot for pharmaceutical company Moderna .

Capacity is an AI-based support automation platform while Citeline Connect is an all-in-one trial recruitment platform created by Informa Pharma Intelligence.

Together, the companies could facilitate clients such as Moderna to develop trial enrolment websites that offer an engaging experience for potential participants.

The combination of Capacity’s chatbot plus support automation software with Citeline’s technology enables users to complete registration and pre-screening via a user-friendly interface.

Capacity CEO David Karandish said: “Our work with Citeline Connect is reflective of our ultimate goal at Capacity, leveraging a company’s existing knowledge base with support automation to help teams do their best work.

“As we see relief from the Covid-19 pandemic on the horizon, there is still a way to go before we are in the clear. In working with Citeline Connect, we’re honoured to have the opportunity to provide helpful technology for healthcare providers, researchers, and patients.”

The partners’ AI-powered enrolment solution is expected to improve the patient experience.

Capacity’s chatbot leverages an easy-to-use technology to deliver a wide knowledge-base and feasible solution.

Citeline Connect chief commercial officer Chris Venezia said: “Working with Capacity is a no-brainer to provide an extensive solution that meets the needs of potential patients and the clinical trial sponsors.

“They make it easy for both potential and current study participants to ask questions, find clinical trial information, and begin their study enrolment journey.”

In addition to Citeline Connect, Informa Pharma Intelligence’s portfolio comprises multiple analysis products, including Sitetrove, Pharmaprojects, Trialtrove and Datamonitor Healthcare.

In June this year, Informa introduced an AI-based platform called Citeline Study Feasibility to expedite trial decisions and timelines.

Designed to provide predictive analytics, the platform can be used to simulate feasibility situations and boost enrolment potential for success over the long term.